IDXX株式は、収益の予想を打破し2025年のガイドラインを上げた後,52週連続のヒット. IDXX stock hit a 52-week high after beating earnings expectations and raising 2025 guidance.

IDEXX Laboratories (IDXX) は,同年11月3日に,第3四半期利益3.40ドル/株を報告した後に,52週間の最高733.52ドルに急上昇し,3.14ドルのコンセンサスを超え,年間13.3%の収益で1105億ドルを記録した. IDEXX Laboratories (IDXX) surged to a 52-week high of $733.52 on November 3, 2025, after reporting third-quarter earnings of $3.40 per share—exceeding the $3.14 consensus—and $1.105 billion in revenue, up 13.3% year-over-year. 同社は2025年度の収益ガイドラインを12.81ドル-13ドル01ドルと収益の予測値4.27ドルから3,300億円に上げ,共同動物グループ,家畜,乳牛及び水質試験部門で強い成果を上げている. The company raised its 2025 earnings guidance to $12.81–$13.01 per share and revenue forecast to $4.27–$4.30 billion, citing strong performance across its Companion Animal Group, livestock and dairy, and water testing segments. アナリストは,StifelとMorgan Stanleyのアップグレードを含む,混合的だが一般的にポジティブな評価で反応し,株式の市場キャピタルは5841億ドルに達し,主要移動平均を上回った. Analysts responded with mixed but generally positive ratings, including upgrades from Stifel and Morgan Stanley, while the stock’s market cap reached $58.41 billion and it outperformed key moving averages.